Central & Eastern Europe Consortium Executive Committee
-
Special Interest Groups
- Clinical Outcome Assessment
- Digital Health
- Emerging and Orphan Therapies
- Global Access to Medical Innovation
- Health Equity Research
- Health Preference Research
- Medical Devices and Diagnostics
- Medication Adherence and Persistence
- Oncology
- Patient-Centered
- Real-World Evidence (RWE)
- Statistical Methods in HEOR
-
Task Forces
- Patient Reported Outcomes (PROs) in Prospective Real World Study Design
- Performance Outcome (PerfO) Assessments
- Preference Heterogeneity in Stated Choice Data
- Surrogate Endpoint Statistical Evaluation for HTA Decision Making
- Valuing HRQoL of Children & Adolescents in Economic Evaluation (Pediatric Utilities)
- Value-Based Healthcare Implementation Special Task Force
- Councils & Roundtables
- Global Groups
- Students
-
New Professionals
-
Professional Development Resources
- What is the Impact of GDPR on the HEOR Community
- Good Practices for HTA - What is out there and how do I use it
- ISPOR & AACP Joint Webinar – “Tips for Securing a Post-Doctoral Fellowship”
- You Are Creative: Research is the First Step
- Good Practices for a Successful Job Search
- Leveraging The Power Of LinkedIn
- Internships & Fellowships: Career Opportunities for the Future
- My Career Path
- Career Advice Across the Globe
- "My ISPOR Story" - Zeba Khan
- "My ISPOR Story" - Lou Garrison
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 1
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 2
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 3
-
Professional Development Resources
- Online Communities
The Consortium Executive Committee is the policy and decision making body of the Consortium.
Consortium members may participate in working committees.
Please contact the ISPOR Global Networks-EMEA Team here with any questions.
Chair
Maciej Niewada, MSc, PhD, MD, MA
Professor, ISPOR Poland Chapter
Warszawa, Poland